Zobrazeno 1 - 2
of 2
pro vyhledávání: '"SP/RBD, spike protein receptor binding domain"'
Autor:
Andrea R Delpero, Larry Karnes, Shannon E. Ronca, Shashikant Nagre, David G. Alleva, Sarah S Webb, Hanne Andersen Elyard, Allison I Jasa, Thomas M. Lancaster, JoAnn Yee, Sylaja Murikipudi, Vidhya Rao, Frans Sollie, Nishit J Shah, Freedom M Green, Melanie M Scully, Jeffrey R Haworth, Thillainaygam Sathiyaseelan, Emma K Greaves, Ramya Ragupathy, Jeffrey Klein, Todd C. Zion
Publikováno v:
Vaccine
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbd52d976e8f0e684d66cd171ccbc43
https://doi.org/10.1016/j.vaccine.2021.09.077
https://doi.org/10.1016/j.vaccine.2021.09.077
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
Autor:
Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
Publikováno v:
Vaccine
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTD
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTD
To address the coronavirus disease 2019 (COVID-19) pandemic caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recombinant subunit vaccine, AKS-452, is being developed comprising an Fc fusion protein of the SARS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323329ba0f3a6ae40363118135c37a0a
http://europepmc.org/articles/PMC8802018
http://europepmc.org/articles/PMC8802018